Home > Healthcare > Medical Devices > Therapeutic Devices > Peripheral Intravenous Catheters Market

Peripheral Intravenous Catheters Market Analysis

  • Report ID: GMI7984
  • Published Date: Jan 2024
  • Report Format: PDF

Peripheral Intravenous Catheters Market Analysis

Based on product, the market is categorized into short PIVC and integrated/closed PIVC. The short peripheral intravenous catheter (PIVC) segment accounted for majority share and was valued at over USD 3.6 billion revenue in 2023.
 

  • Short PIVCs are often preferred for short-term medical treatments, such as administering a single dose of medication, hydration, or delivering short courses of antibiotics. They are frequently utilized in outpatient settings for various procedures that require intravenous access, such as diagnostic tests, minor surgeries, or imaging studies.
     
  • Additionally, these catheters provide ease of insertion as they can be inserted quickly and easily, making them ideal for situations where immediate intravenous access is needed. Their simplicity of use is advantageous in time-sensitive scenarios.
     
  • Moreover, due to their cost-effective nature in comparison to long-term catheters, healthcare providers may choose short PIVCs to minimize expenses associated with catheter use and maintenance.
     
Peripheral Intravenous Catheters Market, By Technology (2023)

Based on technology, the peripheral intravenous catheters market is segmented into conventional PIVC and safety PIVC. The safety PIVC segment held leading revenue share in 2023 and is anticipated to reach USD 7.7 billion by 2032.
 

  • Safety PIVCs incorporate mechanisms that reduce the risk of needlestick injuries during catheter insertion and removal. This is crucial in protecting healthcare professionals from exposure to bloodborne pathogens. The adoption of safety PIVCs aligns with efforts to create a safer working environment, reduce injuries, and improve the overall job satisfaction of healthcare professionals.
     
  • In addition to this, stringent occupational safety regulations and guidelines highlight the importance of using safety devices in healthcare settings. Compliance with these regulations has driven the adoption of safety PIVCs to protect healthcare workers.
     

Based on lumen, the peripheral intravenous catheters market is categorized into single lumen, double lumen, and multi-lumen. The single lumen segment accounted for around USD 2.2 billion revenue size in 2023.
 

  • Single lumen PIVCs are frequently used for the intravenous administration of medications, including antibiotics, pain relievers, antiemetics, and other drugs that do not require separate infusion channels.
     
  • Single lumen PIVCs may be utilized for the transfusion of blood, red blood cells, blood platelets, or plasma when a single access point is sufficient for the intended treatment. They are commonly used for short-term medical treatments, such as one-time infusions or therapies that do not require multiple infusion channels.
     
  • Furthermore, during diagnostic procedures that require intravenous access, such as contrast imaging studies or certain blood tests, single lumen PIVCs are utilized to facilitate the administration of contrast agents or collection of blood samples.
     

Based on end-user segmentation, the peripheral intravenous catheters market is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for majority revenue share and was valued at around USD 3.1 billion revenue in 2023.
 

  • Peripheral IV are essential for delivering intravenous fluids for patients who require fluid resuscitation due to dehydration, shock, or other medical conditions. This is common in emergency departments and critical care units where quick and reliable intravenous access is crucial.
     
  • Additionally, PIVCs are extensively used in pediatric and neonatal units for the administration of medications and fluids to infants and children. Specialized PIVCs designed for smaller veins are often employed in these cases.
     
  • Further, in oncology departments, PIVCs are used for the administration of chemotherapy drugs to cancer patients. They provide a convenient and relatively non-invasive means of accessing the circulatory system.
     
North America Peripheral Intravenous Catheters Market, 2020 – 2032 (USD Billion)

North America peripheral intravenous catheters market accounted for USD 1.8 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • North America has a well-established healthcare infrastructure and a significant amount of awareness and demand for cutting-edge medical advances. The region's effort to offering high-quality patient care is driving a surge in demand for sophisticated and technologically advanced medical equipment, such as peripheral intravenous catheters. Medical facilities in North America prioritize the use of novel technologies that can improve patient outcomes, increase safety, and accelerate medical operations.
     
  • Furthermore, the shift to patient-centered care and outpatient services influences the demand for peripheral intravenous catheters. Healthcare professionals and patients both are looking for catheters that offer maximum comfort, reduce pain during insertion, and render maintenance easier. Manufacturers respond to this need by developing catheters that focus on patient satisfaction and ease. Such developments will further fuel the product demand in the region.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Peripheral intravenous catheters industry reached USD 5.4 billion in 2023 and is set to expand at a 7.7% CAGR from 2024-2032 driven by the advancements in catheter technology, the prevalence of infectious diseases along with favorable government initiatives and healthcare policies.

Short peripheral intravenous catheter (PIVC) market generated more than USD 3.6 billion in revenue in 2023 and is projected to witness high demand through 2032 attributed to the benefits of ease of insertion, simplicity of use, and cost-effectiveness.

North America peripheral intravenous catheters industry was USD 1.8 billion in revenue in 2023 and is poised to record substantial gains by the end of 2032 driven by the presence of a well-established healthcare infrastructure.

Some of the leading peripheral intravenous catheter firms are AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, ICU Medical, Inc., Lineus Medical, MedSource Labs, Retractable Technologies Inc., Teleflex Incorporated, Terumo Corporation, VOGT Medical, and Vygon.

Peripheral Intravenous Catheters Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 256
  • Countries covered: 22
  • Pages: 120
 Download Free Sample